Cargando…
Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis
Cytomegalovirus (CMV) is a common infection occurring in patients undergoing solid organ transplantation (SOT) or hematopoietic stem cell transplantation (HSCT). CMV-specific hyperimmunoglobulin (CMVIG) has been used for the past four decades and is typically administered either prophylactically or...
Autores principales: | Barten, Markus J., Baldanti, Fausto, Staus, Alexander, Hüber, Christian M., Glynou, Kyriaki, Zuckermann, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955988/ https://www.ncbi.nlm.nih.gov/pubmed/35330112 http://dx.doi.org/10.3390/life12030361 |
Ejemplares similares
-
Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival
por: Kornberg, Arno, et al.
Publicado: (2020) -
Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal–fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis
por: Seidel, Vera, et al.
Publicado: (2020) -
Acute Cytomegalovirus Infection as a Cause of Venous Thromboembolism
por: Rinaldi, Francesca, et al.
Publicado: (2014) -
Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis
por: Chuleerarux, Nipat, et al.
Publicado: (2021) -
BK Virus: A Cause for Concern in Thoracic Transplantation?
por: Barten, Markus J., et al.
Publicado: (2018)